Dr. Christopher Richardson is an Associate Professor in the Department of Dermatology and Division of Allergy, Immunology and Rheumatology (AIR) in the Department of Medicine. He completed his medical school and dermatology training at the University of Rochester. He practices general dermatology w...

Certified Specialties

Dermatology - American Board of Dermatology

Faculty Appointments

Associate Professor - Department of Dermatology (SMD)

Associate Professor - Department of Medicine, Allergy/Immunology and Rheumatology (SMD) - Joint

Credentials

Residency & Fellowship

Residency, Dermatology, University of Rochester Medical Center. 2014 - 2017

Internship, Internal Medicine, University of Rochester Medical Center. 2013 - 2014

Education

MD | University of Rochester School of Medicine/Dentistry. 2013

Awards

Alpha Omega Alpha (AOA) Honor Medical Society, Alumnae Inductee. 2024

Medical Dermatology Society Mentorship Award. 2017

Victor Meyer Emmel Prize in Histology. 2004

Research

Dr. Richardson is an immunologist who studies autoimmune diseases of the skin. Much of his research experience has focused on the role of B cells and antibodies in cutaneous and systemic lupus erythematosus. He has ongoing research projects involving cutaneous lupus, dermatomyositis, and scleroderm...

Research Lab

Human Skin Immunology

Visit Lab Website

Clinical Trials

Exploratory Study of Ruxolitinib Cream for the Treatment of Discoid Lupus Erythematosus

Lead Researcher: Christopher Richardson

The purpose of this study is to assess the potential beneficial effect of ruxolitinib cream for the treatment of discoid lupus erythematosus. There are no creams specifically FDA-approved for use in lupus and a great need exists for new treatments. R...

Publications

Journal Articles

Rapid response of omalizumab-resistant chronic urticaria to acalabrutinib.

JAAD case reports.. 2024 May 47 :47-49. Epub 03/15/2024.

Lack of cutaneous B cells differentiates lupus-like skin disease in MRL/lpr mice from human discoid lupus.

Yon J, Curran T, Richardson CT

The Journal of investigative dermatology.. 2023 December 13 Epub 12/13/2023.

Wong-type dermatomyositis with interstitial lung disease and anti-SRP and -PM/Scl antibodies treated with intravenous immunoglobulin.

Kowalski EH, Kenney HM, Richardson CT

JAAD case reports.. 2023 November 41 :26-29. Epub 09/09/2023.

Successful treatment of severe chronic cutaneous lupus with anifrolumab: A series of 6 cases.

Kowalski EH, Stolarczyk A, Richardson CT

JAAD case reports.. 2023 July 37 :21-29. Epub 05/04/2023.

Serologic differences between dermatomyositis and antisynthetase syndrome using a commercially available autoantibody panel: a retrospective cohort study.

Narayan N, Richardson CT

Journal of the American Academy of Dermatology.. 2023 June 28 Epub 06/28/2023.

Differential effect of the 2019 EULAR/ACR classification criteria for systemic lupus on different cutaneous lupus subtypes.

Shah S, Esaa FS, Baughman L, Gadarowski MB, Richardson CT

Journal of the American Academy of Dermatology.. 2023 February 3 Epub 02/03/2023.

Multiple myositis-specific autoantibodies in dermatomyositis: 2 cases and review of the literature.

Narayan N, Richardson CT

JAAD case reports.. 2022 July 25 :72-74. Epub 06/03/2022.

Prominent B cell signature differentiates discoid from subacute cutaneous lupus erythematosus.

Lerman I, Bawany F, Whitt W, Esaa F, Yon J, Babkowski N, Rapp MB, Scott GA, Anolik JH, Richardson CT

The Journal of investigative dermatology.. 2022 May 17 Epub 05/17/2022.

Methotrexate injection site reactions: Case report and literature review.

Kaur J, Zambito J, Richardson CT

JAAD case reports.. 2022 May 23 :79-82. Epub 03/26/2022.

Locally recurrent primary cutaneous coccidioidomycosis.

Lee G, Scott GA, Munsiff SS, Richardson CT

JAAD case reports.. 2021 October 16 :161-163. Epub 09/08/2021.

Human cutaneous B cells: what do we really know?

Lerman I, Mitchell DC, Richardson CT

Annals of translational medicine.. 2021 March 9 (5):440. Epub 1900 01 01.

Degos Disease (Malignant Atrophic Papulosis) With Granular IgM on Direct Immunofluorescence.

Pukhalskaya T, Stiegler J, Scott G, Richardson CT, Smoller B

Cure?us.. 2021 January 1313 (1):e12677. Epub 01/13/2021.

Congenital absence of the skin secondary to the self-improving subtype of dystrophic epidermolysis bullosa with recurrent lesions throughout early childhood.

Dean O, Cusick EH, Grover R, Mercurio MG, Richardson CT

JAAD case reports.. 2021 January 7 :137-140. Epub 12/01/2020.

Remission of anti-TIF1? dermatomyositis after allogeneic hematopoietic stem cell transplant for myelodysplastic syndrome.

Bawany F, Tbakhi B, Mendler JH, Richardson CT, Bennett JM, Aljitawi OS

Blood advances.. 2020 November 244 (22):5698-5701. Epub 1900 01 01.

Autoimmune progesterone dermatitis mimicking facial erythromelalgia successfully treated with hysterectomy and bilateral salpingo-oophorectomy.

Whitt W, Stiegler JD, Richardson CT

JAAD case reports.. 2020 October 6 (10):1104-1106. Epub 08/28/2020.

A Spectrum of Skin Disease: How Staphylococcus aureus Colonization, Barrier Dysfunction, and Cytokines Shape the Skin.

Moran MC, Beck LA, Richardson CT

The Journal of investigative dermatology.. 2020 May 140 (5):941-944. Epub 1900 01 01.

A case of concurrent systemic sclerosis and scleredema.

Mitchell DC, Agnihothri R, Scott GA, Korman B, Richardson CT

JAAD case reports.. 2019 November 5 (11):940-942. Epub 10/24/2019.

An atypical clinical presentation of alopecia in 2 patients with systemic lupus erythematosus.

Lerman I, Agnihothri R, Scott GA, Richardson CT

JAAD case reports.. 2019 November 5 (11):953-956. Epub 10/24/2019.

Anti-TIF1gamma Antibody-Positive Dermatomyositis Associated with Myelodysplastic Syndrome: Response to Treatment.

Lerman I, Richardson CT

Cure?us.. 2019 September 2611 (9):e5775. Epub 09/26/2019.

A unique case of dermatomyositis associated with anti-TIF1? antibody and chondrosarcoma.

Dziwis J, Agnihothri R, Lieberman A, Richardson CT

JAAD case reports.. 2019 September 5 (9):828-830. Epub 09/03/2019.

Failure of B Cell Tolerance in CVID.

Richardson CT, Slack MA, Dhillon G, Marcus CZ, Barnard J, Palanichamy A, Sanz I, Looney RJ, Anolik JH

Frontiers in immunology.. 2019 10 :2881. Epub 12/10/2019.

Successful Treatment of Pemphigus Vulgaris With Ofatumumab

Richardson C, Pentland A, Rapp M

Journal of drugs in dermatology : JDD.. 2018 December 117 (12):1338-1339. Epub 1900 01 01.

Evaluation of the Relationship between Alopecia Areata and Viral Antigen Exposure.

Richardson CT, Hayden MS, Gilmore ES, Poligone B

American journal of clinical dermatology.. 2018 February 19 (1):119-126. Epub 1900 01 01.

Doxycycline is an NF-?B inhibitor that induces apoptotic cell death in malignant T-cells.

Alexander-Savino CV, Hayden MS, Richardson C, Zhao J, Poligone B

Oncotarget.. 2016 November 157 (46):75954-75967. Epub 1900 01 01.

9G4+ autoantibodies are an important source of apoptotic cell reactivity associated with high levels of disease activity in systemic lupus erythematosus.

Jenks SA, Palmer E, Marin E, Hartson L, Chida AS, Richardson C, Sanz I

Arthritis and rheumatism.. 2013 December 65 (12):3165-75. Epub 1900 01 01.

Molecular basis of 9G4 B cell autoreactivity in human systemic lupus erythematosus.

Richardson C, Chida AS, Adlowitz D, Silver L, Fox E, Jenks SA, Palmer E, Wang Y, Heimburg-Molinaro J, Li QZ, Mohan C, Cummings R, Tipton C, Sanz I

The Journal of immunology : official journal of the American Association of Immunologists.. 2013 November 15191 (10):4926-39. Epub 10/09/2013.

Ratings & Comments

At URMC, we believe that patients should be empowered to make the right decisions regarding their personal healthcare. To do so, transparency is critical. URMC partners with Press Ganey, to survey our patients about all aspects of their care experience. We are now putting this pertinent information at your fingertips by displaying star ratings for our providers along with anonymous patient comments on our website. This will help you make better-informed choices about how and with whom you seek care. Click here to learn more about the surveys used to generate this vital information. Learn more about our survey process.

Ratings

During this visit, did this provider spend enough time with you?

4.8

During this visit, did this provider show respect for what you had to say?

4.7

During this visit, did this provider give you easy to understand information about these health questions or concerns?

4.9

During this visit, did this provider listen carefully to you?

4.9

During this visit, did this provider explain things in a way that was easy to understand?

4.8

Patient Comments

5.0

The provider showed excellent knowledge in what should be tried to help solve my issues.

Jan 11, 2024

5.0

Dr Richardson and other staff have always been The Best of my care at SMH/UR

Nov 02, 2023

5.0

I saw both a resident and Dr. Richardson. Both showed concern and clearly explained the lesion on my face, as well as explaining other ways these lesions might appear, their benign nature, and what to look for in suspicious growths on my skin. Use of sunscreen and a broad-brimmed hat were also recommended.

Jul 05, 2023

5.0

Excellent professionalism

Apr 20, 2023

5.0

Dr. Richardson couldn't be more helpful and he always shows his personal concern for my condition. He's always generous with his time. I owe him sincere gratitude for all he has done to help me heal and manage my lupus, and he helped me connect with doctors in [...] (near where I live) to receive the medicine he recommended. After 10 years of not having success with medicines, we have finally found one. Dr. Richardson is responsible for that.

Apr 08, 2023

4.6

Both Drs exceptionally knowledgeable and thorough. Sometimes a little too technical with medical terminology

Mar 12, 2023

5.0

Dr Richardson's specialty in autoimmune dermatology is an exceptional asset to U of R. He is very knowledgeable, professional and engaging.

Mar 04, 2023

5.0

Dr. Richardson and the NP were great! Kind, patient, and willing to take the time to talk and listen about my condition.

Feb 12, 2023

5.0

He was great. Answered all my questions and explained what he was doing and why

Feb 10, 2023

5.0

Courteous, kind and professional

Feb 09, 2023

5.0

We saw both Shimeka and Chris Richardson period. Shameka is very kind and thorough. She took plenty of time and did a thorough exam. Dr. Richardson is always great and helped me feel at ease with the diagnosis.

Jan 27, 2023

5.0

Extremely professional and knowledgeable.

Jan 15, 2023

5.0

Dr. Richardson took his time and was very patient with me while asking him questions regarding my Lupus. At no point in the conversation did he present as rushing me. He answered all of my questions openly and honestly. Such a caring spirit and doctor. Yesssss I would truly recommend him to everyone!

Nov 06, 2022

4.6

Overall a good experience.

Oct 20, 2022

5.0

Far and away the best dermatology team I've ever seen. They took my case very seriously.

Oct 05, 2022

5.0

Dr. Richardson continues to come to my appointments with plans to improve my situation. I respect him.

Sep 02, 2022

5.0

I think with special cases like mine they should give more time with the provider . But overall Dr. Richardson is the Best Dr. That has treated me for my condition In a while. He treats you empathy , compassion and super down to earth. Almost like his own child but professional , not to personal which Is ok .

May 19, 2022

5.0

Dr. Richardson could not be a better doctor.

Apr 09, 2022

5.0

Dr. Richardson and Dr. Bender took their time to hear my concerns, frustration and more importantly assess my need in that moment. Having had a bad experience with the previous provider, I wasn't sure what to expect. Dr. Richardson explained very thoroughly his thoughts regarding my Lupus, possible treatment recommendations and follow up care that's needed. Both providers attentively listened to my concerns and provided insights and did not appear to be in a rush. Thank you!

Apr 08, 2022

5.0

Very good service

Mar 20, 2022

5.0

Dr. Richardson has always been helpful and very inclusive in my mother's concerns and ways to have a successful outcome.

Feb 02, 2022